Kane Biotech Appoints New Advisor - Seite 2

For more information, please visit www.kanebiotech.com, or contact:

Marc Edwards Chief Executive Officer, Kane Biotech Inc. Ray Dupuis Chief Financial Officer, Kane Biotech Inc. Graham Farrell Investor Relations	[phone] [e-mail] [phone] [e-mail]   [phone] [e-mail]

About Harbor Access

Harbor Access represents and advises micro to mega market cap companies. The Company has a measured approach to creating a capital market communications program, which helps optimize their clients’ visibility. Harbor Access brings extensive global experience and professionalism to each client and customizes every solution to meet their clients’ goals.

For more information about Harbor Access, please visit www.harboraccessllc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Information

This press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company’s: (a) financial condition, including lack of significant revenues to date and reliance on equity and other financing; (b) business, including its early stage of development, government regulation, market acceptance for its products, rapid technological change and dependence on key personnel; (c) intellectual property including the ability of the Company to protect its intellectual property and dependence on its strategic partners; and (d) capital structure, including its lack of dividends on its common shares, volatility of the market price of its common shares and public company costs. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by the Company with applicable securities regulatory authorities, available at www.sedar.com. The Company cautions that the foregoing list of factors that may affect future results is not exhaustive.